MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
AGMB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Agomab Therapeutics (AGMB) Ownership - Who owns Agomab Therapeutics?

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1/6 Posthoflei
Phone
+32 33189170
Employees
80
Web
https://www.agomab.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
530.15M
P/E Ratio
N/A
Total Cash
251.98M
Projected Growth
N/A
Total Debt
1.14M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.12
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
AGMB
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for AGMB
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1/6 Posthoflei
Phone
+32 33189170
Employees
80
Web
https://www.agomab.com
Who owns Agomab Therapeutics? AGMB symbol Ownership - Tickeron.com